Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities

Velandai Srikanth, Alan J. Sinclair, Felicia Hill-Briggs, Chris Moran, Geert Jan Biessels

Research output: Contribution to journalReview articlepeer-review

Abstract

Type 2 diabetes and cognitive dysfunction are highly prevalent disorders worldwide. Although type 2 diabetes is associated with an increased risk of dementia, awareness of the link between the two conditions is poor, and few recommendations are available to guide clinicians about how to approach cognitive dysfunction in people with diabetes. Clinical guidelines in diabetes have only recently begun to emphasise the importance of cognitive impairment in diabetes and its management. This Series paper aims to synthesise knowledge about the link between diabetes and cognitive dysfunction, issues pertaining to screening and diagnosis of cognitive impairment and dementia in those with type 2 diabetes, management of diabetes in people with cognitive dysfunction (accounting for age and frailty), and emerging therapies for prevention. A conceptual framework for approaching screening and diagnosis is included, and future research directions to guide the field forward are suggested.

Original languageEnglish (US)
Pages (from-to)535-545
Number of pages11
JournalThe Lancet Diabetes and Endocrinology
Volume8
Issue number6
DOIs
StatePublished - Jun 2020

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint

Dive into the research topics of 'Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities'. Together they form a unique fingerprint.

Cite this